Australia - angielski - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - trimethoprim, quantity: 300 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; sodium starch glycollate; purified talc; magnesium stearate - this product approved for registration as a variation of a product accepted for inclusion in the artg as 'currently supplied' at the commencement of the act. indications are held in artg paper records. previous product number aust r 17577 and 43120. product information not reviewed. indications as at 5 december 1984 : treatment of acute urinary tract infections caused by sensitive organisms.

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadoxine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 40.0 mg/ml; sulfadoxine sulfanyl active 200.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - trimethoprim - unknown - trimethoprim pyrimidine active 0.0 - active constituent

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - trimethoprim - unknown - trimethoprim pyrimidine active 0.0 - active constituent

Malta - angielski - Medicines Authority

p & d pharmaceuticals limited - trimethoprim - tablet - trimethoprim 100 milligram(s) - antibacterials for systemic use

Malta - angielski - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - trimethoprim - tablet - trimethoprim 100 mg - antibacterials for systemic use

Malta - angielski - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - trimethoprim - tablet - trimethoprim 100 mg - antibacterials for systemic use

Australia - angielski - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - trimethoprim, quantity: 16 mg/ml; sulfamethoxazole, quantity: 80 mg/ml - injection, concentrated - excipient ingredients: sodium metabisulfite; propylene glycol; ethanol; diethanolamine; sodium hydroxide; water for injections; hydrochloric acid - indications as at 31 october 2003 :parenteral administration of sulfamethoxazole/trimethoprim is indicated where oral dosage is not desirable or practical, e.g. pre- and post-operative infections associated with surgery, trauma or gynaecology; septicaemia and other infections due to sensitive organisms such as typhoid and paratyphoid.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

bryant ranch prepack - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim. therapy may be initiated prior to obtaining the

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

direct_rx - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa.* *efficacy for this organism in this organ system was studied in fewer than 10 infections. trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.